TP53 and cancer: Manier et al. (2018) also identified recurrent mutated genes, such as KRAS, NRAS, BRAF, and TP53, as well as pan-cancer mutations, somatic copy number alterations (1p and 13q deletion, gain of 1q and 11q), and even subclones not identified in the bone marrow [22].